Who are in the management team of Outlook Therapeutics, Inc.?

Jun 22 2025 10:36 PM IST
share
Share Via
As of March 2022, the management team of Outlook Therapeutics, Inc. includes Executive Chairman Randy Thurman, CEO Lawrence Kenyon, and Directors Gerd Auffarth, Julian Gangolli, Andong Huang, Yezan Haddadin, and Kurt Hilzinger. Kenyon holds multiple key executive roles, including President and CFO.
As of March 2022, the management team of Outlook Therapeutics, Inc. includes the following individuals:

- Mr. Randy Thurman, who serves as the Executive Chairman of the Board.
- Mr. Lawrence Kenyon, who holds multiple roles as President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director.
- Dr. Gerd Auffarth, who is a Director.
- Mr. Julian Gangolli, who is also a Director.
- Andong Huang, who serves as a Director.
- Mr. Yezan Haddadin, who is an Independent Director.
- Mr. Kurt Hilzinger, who is another Independent Director.

In summary, the management team consists of a mix of executive leadership and directors, with Mr. Lawrence Kenyon holding several key executive positions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via
What does Outlook Therapeutics, Inc. do?
Jun 22 2025 06:50 PM IST
share
Share Via
How big is Outlook Therapeutics, Inc.?
Jun 22 2025 06:06 PM IST
share
Share Via